Your browser doesn't support javascript.
loading
The overall safety evaluation of programmed cell death/programmed cell death ligand 1 (PD-1/PD-L1) treatment for lung cancer patients: An updated systematic review and meta-analysis.
Shang, Heli; Zhang, Zewen; Feng, Alei; Yang, Xiaowei; Zhang, Shuisheng; Zhao, Yi; Zhu, Qingshan; Mao, Yantao; Liu, Kun; Tian, Yuan.
Afiliación
  • Shang H; Department of Radiotherapy Oncology, Shandong Provincial Qianfoshan Hospital, The First Hospital Affiliated with Shandong First Medical University.
  • Zhang Z; Department of Imaging and Nuclear Medicine, Qilu Medical College, Shandong University.
  • Feng A; Department of Oncology, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong.
  • Yang X; Department of Hepatobiliary Intervention, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University.
  • Zhang S; Department of General Surgery, Peking University Third Hospital, Beijing.
  • Zhao Y; Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning.
  • Zhu Q; Department of Radiotherapy Oncology, Anyang Cancer Hospital of Henan Province, Anyang, Henan.
  • Mao Y; Department of Oncology, Yantaishan Hospital of Shandong Province, Yantai, Shandong, People's Republic of China.
  • Liu K; Department of Radiotherapy Oncology, Shandong Provincial Qianfoshan Hospital, The First Hospital Affiliated with Shandong First Medical University.
  • Tian Y; Department of Radiotherapy Oncology, Shandong Provincial Qianfoshan Hospital, The First Hospital Affiliated with Shandong First Medical University.
Medicine (Baltimore) ; 98(30): e16439, 2019 Jul.
Article en En | MEDLINE | ID: mdl-31348245
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antígeno B7-H1 / Ipilimumab / Antineoplásicos Inmunológicos / Nivolumab / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Systematic_reviews Idioma: En Revista: Medicine (Baltimore) Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antígeno B7-H1 / Ipilimumab / Antineoplásicos Inmunológicos / Nivolumab / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Systematic_reviews Idioma: En Revista: Medicine (Baltimore) Año: 2019 Tipo del documento: Article